Huang Zhenping, Xu Renfeng, Wang Shaohua, Xia Yuan
Department of Ophthalmology, Nanjing General Hospital of Nanjing Military Command, Nanjing 210002, China.
Yan Ke Xue Bao. 2007 Jun;23(2):84-8.
To compare the long-term curative effect of multifocal intraocular lens Array (AMO) with conventional monofocal intraocular lens AcrySof (Alcon) on functional visual performance, and to evaluate the safety and the effectiveness of the multifocal intraocular lens.
30 cases (60 eyes) after the phacoemulsification with IOL implantation were included. Patients presented for cataract surgery were randomized to receive either Array (AMO) intraocular lens or the AcrySof (Alcon). 15 cases (30 eyes) of multifocal intraocular lens implantation were enrolled at investigational sites. 15 cases (30 eyes) of monofocal intraocular lens implantation were enrolled in a control ground. All the patients were followed up for more than 3 months post operatively. Patients were examined uncorrected distant visual acuity (UCDVA), best corrected distant visual acuity (BCDVA), uncorrected near visual acuity (UCNVA), best corrected near visual acuity (BCNVA), contrast sensitivity (CS) in the best corrected. Contrast sensitivity testing served as the principal outcome measure. All of these people with ocular pathology other than other disease known to affect contrast sensitivity were excluded. All of these people were 50-80 years old. The contrast sensitivity function was measured by one person.
There was no significant difference about BCDVA and BCNVA between two groups (P > 0.05). UCNVA and UCDVA in multifocal intraocular lens group were better than control group (P < 0.05). Postoperative contrast sensitivity testing revealed no statistical significance in 3CPD, 6CPD, 12CPD between two groups (P > 0.05). In 18 CPD, multifocal intraocular lens group were worse than control group (P < 0.05).
Long term curative effect shows that multifocal intraocular lens can offer better visual sight.Contrast sensitivity in two groups has no difference except in 18 CPD.
比较多焦点人工晶状体Array(AMO)与传统单焦点人工晶状体AcrySof(爱尔康)对功能性视觉表现的长期疗效,并评估多焦点人工晶状体的安全性和有效性。
纳入30例(60眼)行白内障超声乳化吸除联合人工晶状体植入术后的患者。拟行白内障手术的患者被随机分为接受Array(AMO)人工晶状体或AcrySof(爱尔康)人工晶状体植入。15例(30眼)接受多焦点人工晶状体植入的患者在研究站点入组。15例(30眼)接受单焦点人工晶状体植入的患者在对照组入组。所有患者术后随访超过3个月。检查患者的未矫正远视力(UCDVA)、最佳矫正远视力(BCDVA)、未矫正近视力(UCNVA)、最佳矫正近视力(BCNVA)、最佳矫正状态下的对比敏感度(CS)。对比敏感度测试作为主要结局指标。排除所有已知患有影响对比敏感度的其他疾病以外的眼部病变患者。所有患者年龄在50 - 80岁。对比敏感度功能由一人测量。
两组间BCDVA和BCNVA无显著差异(P > 0.05)。多焦点人工晶状体组的UCNVA和UCDVA优于对照组(P < 0.05)。术后对比敏感度测试显示两组在3周/度、6周/度、12周/度时无统计学差异(P > 0.05)。在18周/度时,多焦点人工晶状体组比对照组差(P < 0.05)。
长期疗效表明多焦点人工晶状体可提供更好的视力。除在18周/度外,两组对比敏感度无差异。